Table 2.
Nrf2 Activators | Limitations | Advantages |
---|---|---|
Natural exogenous | Poor drug solubility Low oral bioavailability Increased first-pass metabolism Quick biotransformation and elimination Low plasma concentrations Non-specific effects (can act on other signaling pathways, especially at high doses) |
Ingestion with food Available as dietary supplements Affordable due to fair price Increasing clinical trial experience for the treatment of neurodegenerative and neuro-inflammatory CNS disorders (including MS) |
Synthetic exogenous | Lymphocytopenia, leukoencephalopathy | Clinically approved in MS treatment |
Endogenous | Experimental preclinical evidence Preliminary investigational clinical evidence Less affordable due to high price of TPE |
No need for pharmacokinetic (drug delivery) optimization Antioxidant, anti-inflammatory, and immunomodulatory rapid clinical improvement in MS patients |